These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4552884)

  • 1. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin production.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):218-25. PubMed ID: 4552884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiological differentiation of Serratia marcescens: typing by bacteriocin sensitivity.
    Farmer JJ
    Appl Microbiol; 1972 Feb; 23(2):226-31. PubMed ID: 4552885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continued surveillance of Serratia marcescens infections by bacteriocin typing: investigation of two outbreaks of cross-infection in an intensive care unit.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):982-5. PubMed ID: 4555641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocin (marcescin) typing of clinically isolated Serratia marcescens.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):33-43. PubMed ID: 7015560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological surveillance of Serratia marcescens infections by bacteriocin typing.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Dec; 22(6):1058-63. PubMed ID: 4944804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological studies of Serratia marcescens infections by bacteriocin (marcescin) typing.
    Nasu M
    Tohoku J Exp Med; 1981 Jan; 133(1):45-52. PubMed ID: 7015561
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteriocin (Marcescin) typing of clinical isolates of Serratia marcescens.
    Traub WH; Raymond EA; Startsman TS
    Appl Microbiol; 1971 May; 21(5):837-40. PubMed ID: 4930037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Typing of Proteus mirabilis by bacteriocin production and sensitivity as a possible epidemiological marker.
    Kusek JW; Herman LG
    J Clin Microbiol; 1980 Jul; 12(1):112-20. PubMed ID: 6999013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriocin typing of Serratia marcescens. A simplified system.
    Sproat D; Brown A
    Am J Clin Pathol; 1979 Feb; 71(2):172-6. PubMed ID: 371382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Serratia outbreaks in hospital.
    Farmer JJ; Davis BR; Hickman FW; Presley DB; Bodey GP; Negut M; Bobo RA
    Lancet; 1976 Aug; 2(7983):455-9. PubMed ID: 73753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two methods for bacteriocin typing of Serratia marcescens.
    Lai PS; Ngeow YF; Puthucheary SD; Wang CW
    J Clin Microbiol; 1983 Jan; 17(1):1-6. PubMed ID: 6338029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of methods for differentiating among Serratia marcescens isolated from clinical specimens.
    Roemisch E; Kocka FE
    Am J Clin Pathol; 1976 Jul; 66(1):96-100. PubMed ID: 779447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Utility of serotyping in the study of Serratia marcescens infections in Strasbourg Hospitals (author's transl)].
    Minck R; Le Minor S; Pigache F; Dammron A; Reeb E; Kohen M; Le Faou A
    Pathol Biol (Paris); 1980 Oct; 28(8):501-7. PubMed ID: 7001322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of typing methods for Serratia marcescens.
    Anderhub B; Pitt TL; Erdman YJ; Willcox WR
    J Hyg (Lond); 1977 Aug; 79(1):89-102. PubMed ID: 328770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continued epidemiological surveillance of Serratia marcescens infections by bacteriocin typing, with particular reference to strains isolated at Erlangen.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1974; 229(3):372-82. PubMed ID: 4155886
    [No Abstract]   [Full Text] [Related]  

  • 16. An epidemiological study of Serratia marcescens infections by bacteriocin typing.
    Nasu M; Goto J; Goto I
    Microbiol Immunol; 1982; 26(9):795-801. PubMed ID: 6759881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serratia marcescens: biochemical, serological, and epidemiological characteristics and antibiotic susceptibility of strains isolated at Boston City Hospital.
    Wilfert JN; Barrett FF; Ewing WH; Finland M; Kass EH
    Appl Microbiol; 1970 Feb; 19(2):345-52. PubMed ID: 4314379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial outbreak of nitrate-negative Serratia marcescens infections.
    Geiseler PJ; Harris B; Andersen BR
    J Clin Microbiol; 1982 Apr; 15(4):728-30. PubMed ID: 7040469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on group A (phage tail) bacteriocins of Serratia marcescens. I. Phenotypic variation of producer and indicator strains.
    Traub WH; Kleber I
    Zentralbl Bakteriol Orig A; 1973 Dec; 225(2):296-304. PubMed ID: 4150063
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriocin typing of Serratia marcescens isolates of known serotype-group.
    Traub WH
    Appl Microbiol; 1972 May; 23(5):979-81. PubMed ID: 4555640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.